Publication | Closed Access

Design, synthesis and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part I

Medicinal ChemistryBiochemistryBiological EvaluationsNovel OxindolesMedicineNatural SciencesAntiviral Drug DevelopmentHuman RetrovirusAntiviral DrugHivPharmacologyAntiviral CompoundDrug Discovery